Home / Health / Celine Dion's Rare Neurological Battle
Celine Dion's Rare Neurological Battle
31 Mar
Summary
- Stiff-person syndrome affects 1 in a million people globally.
- It's an autoimmune disorder causing painful muscle stiffness and spasms.
- Treatment focuses on managing symptoms and modulating the immune system.

Celine Dion's announcement of her stiff-person syndrome diagnosis in December 2022 shed light on this rare neurological disorder. Affecting approximately one in a million individuals, primarily women between 20 and 50, the condition, first identified in 1956, is characterized by painful muscle stiffness and spasms, often triggered by external stimuli.
Stiff-person syndrome is an autoimmune disorder where the body mistakenly attacks itself, specifically targeting the enzyme glutamic acid decarboxylase (GAD) in many cases. This leads to excessive muscle activity. While a cure remains elusive, current treatments focus on alleviating stiffness and spasms with muscle relaxants and anticonvulsants, alongside immune system modulation therapies.
Treatments like intravenous immunoglobulins are being explored for effectiveness. Alternative therapies, though lacking definitive evidence, include rituximab and plasma exchange. Increasing awareness of stiff-person syndrome is crucial for earlier diagnosis and to accelerate research, ultimately aiming to help patients live fuller lives despite the condition's challenges.